Qiagen
Price & Volume
Stats
See more52W Range | $37.43-$51.88 |
Market Cap | $9.9B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $2B |
Revenue Growth (YoY) | 7.5% |
Gross Profit (12 Mos) | $1.6B |
Diluted EPS | $1.69 |
News
See moreYahoo Finance • 4 days ago
Biobanking Market Analysis and Forecast Report 2025-2035: Ethical and Legal Challenges in Biobanking - Navigating Consent and Privacy
Yahoo Finance • 12 days ago
Qiagen N.V. (QGEN) Launches QIAseq xHYB Panels for Long-Read Sequencing
Yahoo Finance • 13 days ago
Asia-Pacific Non-Invasive Prenatal Testing Market Growth and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen
Yahoo Finance • 26 days ago
QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds
About
CEO | Mr. Thierry Bernard |
CFO | Dr. Roland Sackers |
Address | Hulsterweg 82, Venlo, Netherlands, 5912 PL |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 5,700 |
